– USA, MN – Tactile Systems Technology, Inc. (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, announced the appointment of Laura King to its Board of Directors, effective January 13, 2025.
“We are thrilled to have Laura join our Board of Directors. Tactile will benefit from her considerable experience leading healthcare companies that develop innovative technologies to improve patient care as we continue to expand our impact in lymphedema, airway clearance, and other at-home therapies for people with underserved, chronic conditions,” said Board Chair, Bill Burke.
Laura King will also join the Audit and Compliance & Reimbursement Committees.
About Laura King
Laura King is a seasoned healthcare executive with a 22-year career at General Electric Company, where she served as President & CEO of GE Healthcare’s Global Interventional Business. In this role, she provided clinical solutions for minimally invasive procedures in cardiology, interventional radiology, and surgery. Earlier in her career, she held senior audit and finance roles at GE, including CIO and CFO of Consumer & ECM Motors. Laura King is currently the co-founder and CEO of BiaCure, Inc., a developer of treatments for nail fungus. Previously, she co-founded and served as CEO of Elucent Medical, a surgical navigation platform company, and served as CEO of NeuWave Medical, a minimally invasive tumor ablation system company acquired by Johnson & Johnson’s MedTech division.
About Tactile Systems Technology
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease. The company collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs, and improve the quality of life for tens of thousands of patients each year.
For more, visit www.tactilesystems.com.
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.